For Immediate Release
Integration into one singular brand unlocks value for full product lifecycle management
SCHAUMBURG, Ill.–(BUSINESS WIRE)–November 6, 2014–Sparton Corporation (NYSE:SPA) has announced the completed transition of the Aubrey Group brand to Sparton. In doing so, the Company’s portfolio of services has expanded to include an even greater emphasis on product design and development, and its ability to provide full product lifecycle management for complex medical devices has been significantly enhanced.
“This step will give more transparency as we continue to provide a consolidated range of offerings with one face to the customer and the market alike,” said Dan Kuzniewski, Director of Corporate Marketing for Sparton. “The brand change brings clarity, allowing us to pursue mutually beneficial business engagements across a range of services to help customers bring their products to market more efficiently.”
Sparton’s services include product design and development, complex device contract manufacturing, and aftermarket services such as repair depot and spare parts support. The addition of Aubrey Group establishes the Company’s third design center (Cleveland, OH; Minneapolis, MN; Irvine, CA) with the capabilities and experience to support the medical device industry as well as similar complex products in industrial markets.
“Customers will not only have greater exposure to a range of design and engineering services, but also facilities and resources to transition into full production and product lifecycle management engagements,” said Mike Gaul, Group Vice President of Medical Design and Manufacturing Services. “While the offerings will become more transparent under the Sparton brand, the team in Irvine, CA will remain focused with the resources and expertise to drive product design and development excellence.”
Information pertaining to Sparton’s full range of services can be found by visiting www.sparton.com.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 115th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace, and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has nine manufacturing locations and four engineering design centers worldwide. Sparton’s Web site may be accessed at www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10K and Form 10Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.
Analyst ContactDon Pearson
Office: (847) 762-5812
Media ContactMike Osborne
Office: (847) 762-5814
Investor ContactJohn Nesbett/Jennifer Belodeau
Institutional Marketing Services
Office: (203) 972-9200